Kabazitaksel EVER Pharma 10 mg/ml koncentrat za otopinu za infuziju
Name | Kabazitaksel EVER Pharma 10 mg/ml koncentrat za otopinu za infuziju |
---|---|
Marketing Authorisation Number | HR-H-237716434 |
Active Substance | kabazitaksel hidrat |
Composition | jedan ml koncentrata za otopinu za infuziju sadrži bezvodni ili kabazitaksel hidrat što odgovara 10 mg kabazitaksela |
Pharmaceutical Form | koncentrat za otopinu za infuziju |
Packaging [MA Number for Packaging] | 1 bočica s 4,5 ml koncentrata za otopinu za infuziju, u kutiji [HR-H-237716434-01] 1 bočica s 5 ml koncentrata za otopinu za infuziju, u kutiji [HR-H-237716434-02] 1 bočica s 6 ml koncentrata za otopinu za infuziju, u kutiji [HR-H-237716434-03] |
Manufacturer | Ever Pharma Jena GmbH, Jena, Njemačka Ever Pharma Jena GmbH, Jena, Njemačka |
Marketing Authorisation Holder | EVER Valinject GmbH, Oberburgau 3, Unterach am Attersee, Austrija |
Marketing Authorisation Date | 22.10.2020 |
MA Period of Validity | 22.10.2025 |
Classification Number | UP/I-530-09/19-01/122 |
Registration Number | 381-12-01/30-20-05 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | L01CD04 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Summary of risk management plan | download |